Managing PSC Symptoms: Itching and Fatigue
Last updated:
Primary Sclerosing Cholangitis (PSC) often causes severe itching (pruritus) and profound fatigue due to restricted bile flow. Itch treatment follows a step-wise approach, starting with cholestyramine and advancing to rifampin, other medications, or endoscopic procedures if needed.
Key Takeaways
- • PSC-related itching is a deep, urgent sensation caused by bile buildup, not a typical skin condition.
- • Doctors use a step-wise treatment plan for itching, usually starting with bile acid sequestrants like cholestyramine.
- • Cholestyramine can block the absorption of other medications, making the timing of your daily doses critical.
- • If medications fail to stop the itch, an ERCP procedure may be used to open blocked bile ducts and restore flow.
- • Fatigue in PSC is a profound, physical exhaustion linked to chronic liver inflammation, not just standard tiredness.
For many people with Primary Sclerosing Cholangitis (PSC), the most difficult part of the disease isn’t what shows up on a scan, but symptoms no one else can see: pruritus (intense itching) and profound fatigue [1][2]. These are not just “annoyances”; they are physical manifestations of the disease that drastically alter your daily life.
Understanding and Treating Pruritus
This isn’t a typical skin “itch” caused by an allergy or dry skin; it is a “deep” or “urgent” sensation that comes from within and can be relentless [3][4]. While scientists are still studying the exact cause, they believe the itch is triggered by substances that build up in the blood when bile flow is blocked [5]. One prime suspect is an enzyme called autotaxin, which activates nerve endings [5][6].
A Step-by-Step Approach to Treatment
Because no single “silver bullet” exists for PSC itching, doctors typically follow a “step-wise” plan [7].
1. Bile Acid Sequestrants (First-Line)
The most common starting treatment is cholestyramine [7]. This medicine stays in your digestive tract and “moops up” bile acids so they are excreted.
- Important Note: Cholestyramine is very “sticky” and can prevent your body from absorbing other medications. You must typically take other pills at least 1 hour before or 4 to 6 hours after your dose of cholestyramine [8][9].
2. Rifampin (Second-Line)
If itching persists, doctors often prescribe rifampin [5]. This helps the liver process and eliminate the substances causing the itch [5][10]. Because it can occasionally affect liver enzymes, your doctor will monitor your blood tests closely [10].
3. Opioid Antagonists and SSRIs (Third-Line)
If the first two steps fail, other options include:
- Naltrexone: This medication blocks the body’s natural “opioid” signals, which are thought to play a role in the sensation of itching [5][11].
- Sertraline: Usually known as an antidepressant, this medication (an SSRI) can alter how the brain perceives the itch signal [5][10].
When Medications Aren’t Enough
If pills do not work, your doctor may look for a physical blockage. If an MRI (MRCP) shows a dominant stricture—a severe narrowing in a major bile duct—a doctor may use an ERCP to stretch that area open [2][12]. Opening the duct to let bile flow freely often provides immediate relief from itching [2]. You can learn more about this procedure in the Treatments, Procedures, and Liver Transplant section.
The Reality of PSC Fatigue
Alongside itching, fatigue is the other hallmark symptom of PSC. This is not the standard tiredness you feel after a long day; it is a profound, debilitating exhaustion that sleep does not fix.
The exact cause of this fatigue is not entirely understood, but it is a real, physical symptom of liver disease, likely linked to the brain’s response to chronic inflammation and altered liver metabolism. While there are fewer medical treatments specifically for fatigue compared to itching, recognizing it as a symptom of your disease—rather than a personal failing—is an important first step.
The Impact on Quality of Life
It is important to acknowledge that chronic itching and fatigue are debilitating symptoms that affect over 50% of PSC patients and can lead to [13][4]:
- Severe Sleep Deprivation: Itching often peaks at night, making restful sleep nearly impossible [4][14].
- Mental Health Struggles: Constant discomfort is linked to higher rates of depression, anxiety, and loss of concentration during the day [15][16].
If you are struggling, know that your medical team has many “tools in the shed” to help. Do not hesitate to advocate for a change in your treatment plan if your current medications are not providing relief.
Frequently Asked Questions
Why does PSC cause such severe itching?
What is the first treatment for PSC itching?
How should I take cholestyramine with my other medications?
What happens if pills don't stop my PSC itching?
Why am I always so tired with PSC?
Questions for Your Doctor
- • What is my 'Itch Score' on a scale of 1 to 10, and how should we use that to decide when to start or change medications?
- • Since I am taking cholestyramine, exactly how many hours should I wait before taking my other medications?
- • Does my most recent MRCP show a 'dominant stricture' that might be causing this itch and require an ERCP?
- • If cholestyramine doesn't work, what is the next step in our treatment plan—rifampin, naltrexone, or something else?
- • Are there any clinical trials for 'IBAT inhibitors' or other new itch treatments that I might be eligible for?
Questions for You
- • On a scale of 0 (no itch) to 10 (worst imaginable itch), how has my itching felt over the last 24 hours?
- • How many times in the last week has itching kept me from falling asleep or woken me up during the night?
- • Is my fatigue preventing me from participating in activities I normally enjoy, or making it hard to work?
- • Am I experiencing other symptoms like extreme tiredness or a low mood that might be related to the constant itching?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Fatigue and itch severity in patients with PBC and PSC: Prospective analysis of two large cohorts.
Kruk B, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz P
European journal of clinical investigation 2025; (55(7)):e70041 doi:10.1111/eci.70041.
PMID: 40178005 - 2
[Gastrointestinal endoscopy in the diagnosis and treatment of biliary liver disease].
Liang XY, Ding HG
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2022; (30(7)):690-695 doi:10.3760/cma.j.cn501113-20220427-00222.
PMID: 36038336 - 3
Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study.
Gungabissoon U, Hunnicutt J, McDermott EJ, et al.
BMJ open gastroenterology 2025; (12(1)) doi:10.1136/bmjgast-2025-001809.
PMID: 41381205 - 4
A multinational survey assessing the impact and burden of pruritus on patients with primary sclerosing cholangitis.
Kowdley KV, Safer R, Gomel R, et al.
Hepatology communications 2026; (10(3)) doi:10.1097/HC9.0000000000000904.
PMID: 41678299 - 5
Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE, Namer B, Bolier R, et al.
Digestive diseases (Basel, Switzerland) 2015; (33 Suppl 2()):164-75 doi:10.1159/000440829.
PMID: 26641452 - 6
An update on the physiopathology and therapeutic management of cholestatic pruritus in children.
Thébaut A, Debray D, Gonzales E
Clinics and research in hepatology and gastroenterology 2018; (42(2)):103-109 doi:10.1016/j.clinre.2017.08.007.
PMID: 29031874 - 7
Safety considerations for the management of cholestatic itch.
Trivella J, Levy C
Expert opinion on drug safety 2021; (20(8)):915-924 doi:10.1080/14740338.2021.1915984.
PMID: 33836644 - 8
An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogen.
Morley VJ, Kinnear CL, Sim DG, et al.
eLife 2020; (9()).
PMID: 33258450 - 9
An orally administered drug prevents selection for antibiotic-resistant bacteria in the gut during daptomycin therapy.
Morley VJ, Sim DG, Penkevich A, et al.
Evolution, medicine, and public health 2022; (10(1)):439-446 doi:10.1093/emph/eoac035.
PMID: 36118914 - 10
Comparison of Sertraline with Rifampin in the treatment of Cholestatic Pruritus: A Randomized Clinical Trial.
Ataei S, Kord L, Larki A, et al.
Reviews on recent clinical trials 2019; (14(3)):217-223 doi:10.2174/1574887114666190328130720.
PMID: 30919782 - 11
Pharmacological interventions for pruritus in adult palliative care patients.
Siemens W, Xander C, Meerpohl JJ, et al.
The Cochrane database of systematic reviews 2016; (11()):CD008320 doi:10.1002/14651858.CD008320.pub3.
PMID: 27849111 - 12
Endoscopic Management of Primary Sclerosing Cholangitis.
Barkin JA, Levy C, Souto EO
Annals of hepatology 2017; (16(6)):842-850 doi:10.5604/01.3001.0010.5274.
PMID: 29055922 - 13
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry.
Dean R, Yazdanfar M, Zepeda J, et al.
Hepatology communications 2025; (9(5)) doi:10.1097/HC9.0000000000000703.
PMID: 40366147 - 14
Cholestasis-Associated Pruritus and Its Pruritogens.
Langedijk JAGM, Beuers UH, Oude Elferink RPJ
Frontiers in medicine 2021; (8()):639674 doi:10.3389/fmed.2021.639674.
PMID: 33791327 - 15
Factors that Influence Health-Related Quality of Life in Patients with Primary Sclerosing Cholangitis.
Cheung AC, Patel H, Meza-Cardona J, et al.
Digestive diseases and sciences 2016; (61(6)):1692-9 doi:10.1007/s10620-015-4013-1.
PMID: 26743764 - 16
Patient-Predicted Outcomes Are Associated with Quality of Life in Patients with Primary Sclerosing Cholangitis.
Henson JB, Helzberg JH, Muir AJ
Digestive diseases and sciences 2022; (67(12)):5483-5492 doi:10.1007/s10620-022-07482-z.
PMID: 35347534
This page is for informational purposes only and does not replace professional medical advice. Always consult your hepatologist or healthcare provider about managing your specific PSC symptoms.
Stay up to date
Get notified when new research about Primary sclerosing cholangitis is published.
No spam. Unsubscribe anytime.